BVS Q4 2024 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$154M+13.5% YoY

Gross Profit

$103M66.8% margin

Operating Income

$8M5.2% margin

Net Income

-$156,000-0.1% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

+10.6%

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$728M

Total Liabilities

$542M

Stockholders' Equity

$148M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$154M	$135M	+13.5%
Gross Profit	$103M	$86M	+19.0%
Operating Income	$8M	$1M	+585.7%
Net Income	-$156,000	-$6M	+97.4%

Revenue Segments

U.S. Segment

$135M88%

International Segment

$18M12%

Geographic Segments

UNITED STATES

$135M88%

Non-US

$18M12%